Decreased coexpression of estrogen receptor -α and -β in the hippocampus of the patient with Alzheimer disease

鲁亚平,曾梅,秦松,周江宁

DOI: https://doi.org/10.3760/j.issn:1006-7876.2003.05.003

2003-01-01

Abstract:Objective: To detect the coexpression of estrogen receptor-α and -β (ERα and ERβ) in the hippocampus of the controls and their alterations in AD hippocampus. Methods: Fluorescence immunocytochemistry and confocal laser microscopy were used to examine the coexpression of ERα and ERβ in the hippocampus in 10 controls and 10 AD cases. Results: ERα or ERβ fluorescence immunoreactivity was widely observed in neurons concentrated predominantly in the stratum pyramidale and sparsely in the stratum radiatum and oriens of the hippocampus both in the controls and AD cases. The labeled pyramidal neurons for ERα or ERβ were exhibited with immunoreactivity mainly in the cytoplasm and little in the nucleus. Double-label fluorescence immunocytochemistry for ERα and ERβ in the same individual cells might be divided into three types. (1) Double-cytoplasmic-staining cells; (2) Double-nuclear-staining cells; (3) ERα-nuclear-staining and Eβ-cytoplasmic-staining cells. There were significant decreases in the ratio of double-nuclear-staining neurons to ERα positive neurons (2.6% ± 0.5%) or to ERβ positive neurons (1.7% ± 0.3%) in the subfield CA1 of AD hippocampus in comparison with that of the controls (5.0% ± 0.7%, P < 0.001; 3.9% ± 0.6%, P < 0. 001; respectively). Conclusion: The decreased double-nuclear-staining cells in AD hippocampus might play an important role in process of AD pathology.